company background image
3613 logo

Beijing Tong Ren Tang Chinese Medicine SZSC:3613 Stock Report

Last Price

HK$8.42

Market Cap

HK$7.0b

7D

1.8%

1Y

-28.0%

Updated

23 Dec, 2024

Data

Company Financials +

Beijing Tong Ren Tang Chinese Medicine Company Limited

SZSC:3613 Stock Report

Market Cap: HK$7.0b

3613 Stock Overview

Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals. More details

3613 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth3/6
Past Performance1/6
Financial Health5/6
Dividends4/6

My Notes

Capture your thoughts, links and company narrative

Beijing Tong Ren Tang Chinese Medicine Company Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Beijing Tong Ren Tang Chinese Medicine
Historical stock prices
Current Share PriceHK$8.42
52 Week HighHK$12.44
52 Week LowHK$7.03
Beta0.44
1 Month Change7.26%
3 Month Change9.35%
1 Year Change-28.03%
3 Year Change-33.60%
5 Year Change-26.78%
Change since IPO-46.16%

Recent News & Updates

Recent updates

Shareholder Returns

3613HK PharmaceuticalsHK Market
7D1.8%0.3%0.8%
1Y-28.0%-3.8%21.1%

Return vs Industry: 3613 underperformed the Hong Kong Pharmaceuticals industry which returned -3.9% over the past year.

Return vs Market: 3613 underperformed the Hong Kong Market which returned 19.9% over the past year.

Price Volatility

Is 3613's price volatile compared to industry and market?
3613 volatility
3613 Average Weekly Movement5.8%
Pharmaceuticals Industry Average Movement6.4%
Market Average Movement8.8%
10% most volatile stocks in HK Market18.6%
10% least volatile stocks in HK Market4.1%

Stable Share Price: 3613 has not had significant price volatility in the past 3 months compared to the Hong Kong market.

Volatility Over Time: 3613's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1669779Wang Chiwww.tongrentangcm.com

Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals. The company operates through three segments: Hong Kong, Mainland China, and Overseas. It also offers Chinese medical consultation and treatment services.

Beijing Tong Ren Tang Chinese Medicine Company Limited Fundamentals Summary

How do Beijing Tong Ren Tang Chinese Medicine's earnings and revenue compare to its market cap?
3613 fundamental statistics
Market capHK$7.05b
Earnings (TTM)HK$494.14m
Revenue (TTM)HK$1.38b

14.3x

P/E Ratio

5.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
3613 income statement (TTM)
RevenueHK$1.38b
Cost of RevenueHK$384.69m
Gross ProfitHK$991.96m
Other ExpensesHK$497.83m
EarningsHK$494.14m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.59
Gross Margin72.06%
Net Profit Margin35.89%
Debt/Equity Ratio0.006%

How did 3613 perform over the long term?

See historical performance and comparison

Dividends

3.9%

Current Dividend Yield

56%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 05:12
End of Day Share Price 2024/12/23 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Beijing Tong Ren Tang Chinese Medicine Company Limited is covered by 8 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yanyin ZhuChina International Capital Corporation Limited
null nullCMB International Securities Limited
Christina ChenHSBC